Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA OKs Vertex Drug For Cystic Fibrosis; $294K/Yr
Pharmalot
Tuesday, January 31, 2012 - 3:07pm
tags:
FDA, cystic fibrosis, Vertex Pharmaceuticals, Kalydeco
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
Seeking Alpha
Tuesday, January 31, 2012 - 2:44pm
tags:
Abbott Laboratories, Apricus Biosciences, Warner Chilcott, BioSante
GlaxoSmithKline Poised To Break 52-Week High
Seeking Alpha
Tuesday, January 31, 2012 - 2:43pm
tags:
GSK, JNJ, Merck, Pfizer, Abbott Laboratories, Human Genome Sciences, Bristol-Myers Squibb
AcelRx rallies on drug study update
Marketwatch
Tuesday, January 31, 2012 - 2:41pm
tags:
AcelRx, ARX-01
Actelion Counts on ‘Make or Break’ Lung Drug
Bloomberg
Tuesday, January 31, 2012 - 8:06am
tags:
Actelion, macitentan
Which Big Biotech Is the Best Bet?
Motley Fool
Tuesday, January 31, 2012 - 8:01am
tags:
Gilead, Amgen, Celgene, Biogen Idec
3 Biotech Buyout Candidates for 2012
Motley Fool
Tuesday, January 31, 2012 - 8:00am
tags:
Vertex Pharmaceuticals, ONYX Pharmaceuticals, Acorda, Biogen Idec, GSK, Novartis, Bayer, Pfizer, Teva Pharmaceuticals, Merck, JNJ
FDA Pharma Meetings for February
Motley Fool
Tuesday, January 31, 2012 - 7:58am
tags:
FDA, Amgen, Xgeva, Cell Therapeutics, Pixuvri, Vivus, Qnexa, Chelsea Therapeutics, Northera
Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug
Yahoo/AP
Tuesday, January 31, 2012 - 7:56am
tags:
Allos, Europe, lymphoma, Folotyn
Pfizer 4Q net falls by half after generic Lipitor
Yahoo/AP
Tuesday, January 31, 2012 - 7:50am
tags:
earnings, Lipitor, Pfizer
Orexo Falls as Much as 20% After J&J Drug Research Deal Canceled
Bloomberg
Tuesday, January 31, 2012 - 7:49am
tags:
Orexo, JNJ
Glaxo, Lilly, Pfizer Said to Be Interested in Turkey’s MN Pharma
Bloomberg
Tuesday, January 31, 2012 - 7:48am
tags:
GSK, Eli Lilly, Pfizer, Turkey, MN Pharma, M&A, Mustafa Nevzat, Mylan, Abbott Laboratories
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Seeking Alpha
Tuesday, January 31, 2012 - 7:47am
tags:
Dendreon, Provenge, prostate cancer, JNJ, Zytiga
Expecting Catalyst Action For Astex Pharmaceuticals
Seeking Alpha
Tuesday, January 31, 2012 - 7:42am
tags:
Astex, Dacogen, small molecule drugs
Eli Lilly net income falls 27% as patents expire
Marketwatch
Tuesday, January 31, 2012 - 7:41am
tags:
earnings, Eli Lilly
J&J to replace Tylenol unit management: report
Yahoo/AP
Tuesday, January 31, 2012 - 7:33am
tags:
JNJ, Tylenol, recalls, McNeil
FDA nod fuels Bydureon vs. Victoza bout
Fierce Pharma
Monday, January 30, 2012 - 4:00pm
tags:
Victoza, diabetes, Bydureon, FDA, Amylin, Novo Nordisk, Alkermes
GTx soars after Citigroup predicts drug trial results will be positive
The Fly on the Wall
Monday, January 30, 2012 - 3:58pm
tags:
GTx, ostarine
FDA Approves Roche, Curis Skin-Cancer Drug
TheStreet.com
Monday, January 30, 2012 - 3:57pm
tags:
Curis, Roche, FDA, skin cancer, Erivedge
Earnings Preview: Biogen
Yahoo/Zacks
Monday, January 30, 2012 - 3:54pm
tags:
earnings, Biogen Idec

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.